Bayer Could Resolve Most of Legal Threat With U.S. Supreme Court Ruling, Barclays Says -- Market Talk

Dow Jones06-23

1006 GMT - Bayer shares trade at a significant discount to peers due to litigation, but the majority of the outstanding threat would be removed by a favorable U.S. Supreme Court decision on its Roundup weedkiller, Barclays analysts say. The German agricultural and pharmaceutical group is awaiting a Supreme Court decision in late June or early July, which could send shares up 14% or down 13% depending on the ruling, according to Barclays. While a successful outcome on a related class-action settlement of $7.25 billion is needed to fully resolve the litigation threat, a favorable Supreme Court ruling alone could address most of the risk, the analysts say. The Supreme Court could create a strong precedent in Bayer's favor and reduce the attractiveness of taking the company to court for potential plaintiffs, they add. Shares rise 0.1%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

June 23, 2026 06:06 ET (10:06 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2645887042?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645887042","market":"us","top_or_hot":-1,"title":"Bayer Could Resolve Most of Legal Threat With U.S. Supreme Court Ruling, Barclays Says -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1006 GMT - Bayer shares trade at a significant discount to peers due to litigation, but the majority of the outstanding threat would be removed by a favorable U.S. Supreme Court decision on its Roundup weedkiller, Barclays analysts say. The German agricultural and pharmaceutical group is awaiting a Supreme Court decision in late June or early July, which could send shares up 14% or down 13% depending on the ruling, according to Barclays. While a successful outcome on a related class-action settlement of $7.25 billion is needed to fully resolve the litigation threat, a favorable Supreme Court ruling alone could address most of the risk, the analysts say. The Supreme Court could create a strong precedent in Bayer's favor and reduce the attractiveness of taking the company to court for potential plaintiffs, they add. Shares rise 0.1%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 23, 2026 06:06 ET (10:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer Could Resolve Most of Legal Threat With U.S. Supreme Court Ruling, Barclays Says -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer Could Resolve Most of Legal Threat With U.S. Supreme Court Ruling, Barclays Says -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-23 18:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1006 GMT - Bayer shares trade at a significant discount to peers due to litigation, but the majority of the outstanding threat would be removed by a favorable U.S. Supreme Court decision on its Roundup weedkiller, Barclays analysts say. The German agricultural and pharmaceutical group is awaiting a Supreme Court decision in late June or early July, which could send shares up 14% or down 13% depending on the ruling, according to Barclays. While a successful outcome on a related class-action settlement of $7.25 billion is needed to fully resolve the litigation threat, a favorable Supreme Court ruling alone could address most of the risk, the analysts say. The Supreme Court could create a strong precedent in Bayer's favor and reduce the attractiveness of taking the company to court for potential plaintiffs, they add. Shares rise 0.1%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 23, 2026 06:06 ET (10:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2645887042","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645887042","pubTimestamp":1782209160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1006 GMT - Bayer shares trade at a significant discount to peers due to litigation, but the majority of the outstanding threat would be removed by a favorable U.S. Supreme Court decision on its Roundup weedkiller, Barclays analysts say. The German agricultural and pharmaceutical group is awaiting a Supreme Court decision in late June or early July, which could send shares up 14% or down 13% depending on the ruling, according to Barclays. While a successful outcome on a related class-action settlement of $7.25 billion is needed to fully resolve the litigation threat, a favorable Supreme Court ruling alone could address most of the risk, the analysts say. The Supreme Court could create a strong precedent in Bayer's favor and reduce the attractiveness of taking the company to court for potential plaintiffs, they add. Shares rise 0.1%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G.","BK4007":"制药"},"translate_title":"巴克莱表示，拜耳可以通过美国最高法院的裁决解决大部分法律威胁——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"1006 GMT - Bayer shares trade at a significant discount to peers due to litigation, but the majority of the outstanding threat would be removed by a favorable U.S. Supreme Court decision on its Roundup weedkiller, Barclays analysts say. The German agricultural and pharmaceutical group is awaiting a Supreme Court decision in late June or early July, which could send shares up 14% or down 13% depending on the ruling, according to Barclays. While a successful outcome on a related class-action settlement of $7.25 billion is needed to fully resolve the litigation threat, a favorable Supreme Court ruling alone could address most of the risk, the analysts say. The Supreme Court could create a strong precedent in Bayer's favor and reduce the attractiveness of taking the company to court for potential plaintiffs, they add. Shares rise 0.1%. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 23, 2026 06:06 ET (10:06 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2645887042","isCrawlerRequest":true}